Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
Work
Year: 2012
Type: article
Abstract: Background The primary objective of this study was to test whether oncolytic herpes simplex virus type 1 (HSV1) could eradicate chemoresistant cancer stem cells (CSCs). Methods The fluorescent aldefl... more
Source: BMC Cancer
Institutions Chinese Academy of Medical Sciences & Peking Union Medical College, Capital Medical University, Beijing Anzhen Hospital, Nankai University
Cites: 75
Cited by: 42
Related to: 10
FWCI: 2.446
Citation percentile (by year/subfield): 88.88
Subfield: Genetics
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,195